Market closedNon-fractional

Vera Therapeutics/VERA

13:30
14:25
15:15
16:10
17:00
1D1W1MYTD1YMAX

About Vera Therapeutics

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

Ticker

VERA

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology

Headquarters

Brisbane, United States

Employees

55
Website
veratx.com

VERA Metrics

BasicAdvanced
$1.9B
Market cap
-
P/E ratio
-$2.05
EPS
1.11
Beta
-
Dividend rate
$1.9B
1.11
28.63
27.757
14.421
15.065
-26.91%
-20.24%
-36.89%
5.35
5.35
-16.11
-39.85%
-76.85%

What the Analysts think about VERA

Analyst Ratings

Majority rating from 10 analysts.
Buy

VERA Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
0.00% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$0
NaN%
Net income
-$28M
10.55%
Profit margin
0.00%
NaN%

VERA Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 5.66%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.46
-$0.45
-$0.60
-$0.56
-
Expected
-$0.69
-$0.53
-$0.51
-$0.53
-$0.56
Surprise
-33.65%
-15.62%
18.16%
5.66%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Vera Therapeutics stock?

Vera Therapeutics (VERA) has a market cap of $1.9B as of July 05, 2024.

What is the P/E ratio for Vera Therapeutics stock?

The price to earnings (P/E) ratio for Vera Therapeutics (VERA) stock is 0 as of July 05, 2024.

Does Vera Therapeutics stock pay dividends?

No, Vera Therapeutics (VERA) stock does not pay dividends to its shareholders as of July 05, 2024.

When is the next Vera Therapeutics dividend payment date?

Vera Therapeutics (VERA) stock does not pay dividends to its shareholders.

What is the beta indicator for Vera Therapeutics?

Vera Therapeutics (VERA) has a beta rating of 1.11. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Buy or sell Vera Therapeutics stock

Buy or sell Vera Therapeutics stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing